Law360, New York ( January 14, 2013, 2:11 PM EST) -- United States courts are increasingly confronting litigation involving U.S. publicly traded issuers based in the People's Republic of China (PRC or China). This litigation often raises complex issues related to the interaction (and potential conflicts) between U.S. and Chinese law, and in particular the use in U.S. litigation of documents filed with (or subject to the supervision and control of) Chinese regulators. Courts will likely continue to confront these issues, as there are over 100 U.S. publicly traded Chinese issuers and initial public offerings of Chinese companies in the U.S. are expected to increase.[1]...